A Study of Avutometinib (VS-6766) + Defactinib in Recurrent KRAS G12V, Other KRAS and BRAF Non-Small Cell Lung Cancer
Clinical trial NCT04620330 · COMPLETED
Trial details
- NCT number
- NCT04620330
- Sponsor
- Verastem, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-31
- Primary completion
- 2023-08-29
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.